Pharmaceutical composition for treating atherosclerosis and application thereof

A technology of atherosclerosis and composition, applied in the field of medicine, can solve problems such as unsatisfactory effects, and achieve the effects of natural non-toxic long-term administration, suitable for long-term administration, and obvious effects

Inactive Publication Date: 2016-10-12
王双喜
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

General prevention is mainly based on reasonable diet, physica

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating atherosclerosis and application thereof
  • Pharmaceutical composition for treating atherosclerosis and application thereof
  • Pharmaceutical composition for treating atherosclerosis and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A pharmaceutical composition for treating atherosclerosis. The pharmaceutical composition is prepared from the following raw materials: 101 parts of corydalin, 6 parts of sophoside, and 9 parts of kaempferoside.

Embodiment 2

[0036] A pharmaceutical composition for treating atherosclerosis, which is prepared from the following raw materials: 0.5 parts of corydalin, 105 parts of sophoside, and 102 parts of kaempferoside.

Embodiment 3

[0038] A pharmaceutical composition for treating atherosclerosis, which is prepared from the following raw materials: 103 parts of corydalin, 7 parts of sophoside, and 103 parts of kaempferoside.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to a pharmaceutical composition for treating atherosclerosis and its application; the pharmaceutical composition is prepared from the following raw materials: cyclovir buxicine D, barretoxin, and swertiamarin; it has stable quality control, It is safe and effective, natural and non-toxic, and suitable for long-term use.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating atherosclerosis and its application. Background technique [0002] Atherosclerosis is a kind of arteriosclerosis, which mainly occurs in the intima of large and medium arteries, and yellow atheromatous plaques containing cholesterol and fats appear, which are mostly caused by lipid metabolism disorders and neurovascular dysfunction. Often lead to thrombosis, blood supply disorders. The onset of atherosclerosis is more common in men over 40 years old and postmenopausal women. The disease is often accompanied by hypertension, hypercholesterolemia or diabetes. Atherosclerosis is a common disease, frequently-occurring disease, one of the diseases with high mortality and disability, which seriously endangers human life and health. It is common in mental workers and is also one of the main causes of death in the elderly. . [0...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P9/10A61K31/4355
CPCA61K31/7048A61K31/4355A61K2300/00
Inventor 王双喜潘国聘张崇马丽娟杨晶晶王福梁文静马慧李鹏万光瑞
Owner 王双喜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap